Prospective Validation of the STOPSHOCK Score for Early Cardiogenic Shock Prediction in Acute Coronary Syndrome: A Real-World Perspective

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Abiomed; Janssen Pharmaceuticals; Cardurion; Novartis</li><li>Equity/Stock(s)/Options - Seerlinq</li><li> - Seerlinq</li></ul>